Kristina Raspe receives leadership award
Kristina Raspe, vice president for real estate development and asset management at USC, was recently honored with a Visionary Leadership award by the Asian American Architects/Engineers (AAa/e) association. She received the award at the organization’s 35th annual awards banquet in Los Angeles earlier this month.
“We recognize that USC plays a vital role in the development of Los Angeles’ built environment,” AAa/e board of directors member Sonnet Hui wrote in a memo. “And in line with our theme for this year, Embrace the Spirit of the Dragon, Kristina’s leadership qualities, her strong commitment to sustainable growth and her continued dedication to the revitalization of the local community is truly inspirational and visionary.”
The AAa/e is a nonprofit organization dedicated to providing a voice to emerging businesses in the field of architecture, engineering and construction.
Safety fair to cover key topics on Health Sciences Campus
The annual USC Campus Safety and Emergency Preparedness Fair will be held Wednesday on the Health Sciences Campus.
Offering information on a broad range of safety topics, the event will run from 10 a.m. to 2 p.m. at the Harry and Celesta Pappas Quad.
Information booths will provide safety tips, and demonstrations are scheduled throughout the day. Emergency preparedness kits and fire extinguishers will be available for purchase.
The event is sponsored by the USC Department of Public Safety, the USC Fire Safety Office, and the Office of Environmental Health and Safety.
Pharmacy students receive national scholarships
For the first time, students from the USC School of Pharmacy have been recognized by the scholarship committee of the National Association of Medical Minority Educators (NAMME).
Henry Delu and Folayemi Fashola, both PharmD candidates and Rho Chi honor students, received scholarships at the 37th NAMME Annual Conference, which took place last month in National Harbor, Md.
Created in 1995, the annual NAMME scholarship is awarded to underrepresented minority students who have completed the first year of health professions training. Nominated students are selected based upon their academic record, community service, financial need and personal statement.
Delu and Fashola boast strong academic records and have a long-standing commitment to community service. In addition to his academic standing, Delu served as co-chair for the Diabetes Initiative as part of the USC chapter of the Student National Pharmaceutical Association (SNPhA).
Fashola has also been actively involved with SNPhA, serving as the group’s vice president, and has participated in various activities as a Kaiser Permanente pharmacy intern.
“The NAMME scholarship is an honor, but more importantly it’s a nod of encouragement for me to continue putting my best foot forward,” she said. “It also pushes me to intensify my mentorship efforts to increase minority representation in pharmacy.”
Lieberman heads orthopaedics department
Jay Lieberman, an internationally recognized clinician and researcher, has been named professor and chair of the Department of Orthopaedic Surgery at the Keck School of Medicine of USC. He will also serve as orthopaedist-in-chief at the Keck Medical Center of USC, director of the USC Institute of Orthopaedics and chief of orthopaedics at the Los Angeles County+USC Medical Center.
Lieberman comes to the Keck School from the University of Connecticut Health Center, where he served as professor and chair of the Department of Orthopaedic Surgery and director of the New England Musculoskeletal Institute. He is known as a leading authority on total joint arthroplasty and the treatment of osteonecrosis of the hip.
Lieberman succeeds Michael Patzakis, who recently retired after 21 years as chair of the Department of Orthopaedic Surgery.
“I am honored by this appointment,” Lieberman said. “The Department of Orthopaedic Surgery at USC has a long tradition of excellence, and I hope to build on the legacy established by Dr. Patzakis. We will not only provide superb clinical care but be on forefront of the development of new therapies and procedures that will benefit our patients.”